Excited to share our work on the association of Modifier 22 with challenging pancreaticoduodenectomies. @raheeljajja
Factors such as neoadjuvant chemotherapy, obesity and chronic pancreatitis were significantly associated with Modifier 22 use in pancreaticoduodenectomy. Perioperative characteristics that lead to its addition may be used to further delineate difficult pancreaticoduodenectomies. journals.lww.com/journalacs/Fulā¦View quoted post on X